Title 21, Food and DrugsRelease 119-110

§1533 Information Collection and Dissemination with Respect to Grant Recipients

Title 21 › CHAPTER 20 — NATIONAL DRUG CONTROL PROGRAM › SUBCHAPTER II — DRUG-FREE COMMUNITIES › Part A — Drug-Free Communities Support Program › § 1533

Last updated Sep 22, 2026|Official source

Summary

The Administrator can look at any books, records, or papers tied to a grant or a grant renewal and may ask grant recipients for information to check they meet the rules in section 1532(a). The Administrator must put out a request for proposals that explains how to apply, how renewals work, and when a renewal can be held back. Applications must be written and will be reviewed. Reporting should be kept as simple as the law allows, and renewal requests should be handled quickly when possible. The Administrator may collect data from national substance-use groups, federal, state, local, or tribal agencies, and other groups working on related activities. The Administrator can evaluate specific efforts and the whole program and share results with coalitions and the public. These activities must be done with the Advisory Commission and the National Community Antidrug Coalition Institute. Money for program evaluation cannot come from amounts under section 1524(a), except administrative funds available under section 1524(b).

Full Legal Text

Title 21, §1533

Food and Drugs, Source: USLM XML via OLRC

(a)Coalition information
(1)General auditing authority
For the purpose of audit and examination, the Administrator— (A)
(B)may periodically request information from a grant recipient to ensure that the grant recipient meets the applicable criteria under section 1532(a) of this title.
(2)Application process
The Administrator shall issue a request for proposal regarding, with respect to the grants awarded under section 1532 of this title, the application process, grant renewal, and suspension or withholding of renewal grants. Each application under this paragraph shall be in writing and shall be subject to review by the Administrator.
(3)Reporting
The Administrator shall, to the maximum extent practicable and in a manner consistent with applicable law, minimize reporting requirements by a grant recipient and expedite any application for a renewal grant made under this part.
(b)Data collection and dissemination
(1)In general
The Administrator may collect data from—
(A)national substance use and misuse organizations that work with eligible coalitions, community anti-drug coalitions, departments or agencies of the Federal Government, or State or local governments and the governing bodies of Indian tribes; and
(B)any other entity or organization that carries out activities that relate to the purposes of the Program.
(2)Activities of Administrator (3) Consultation
The Administrator may—
(A)evaluate the utility of specific initiatives relating to the purposes of the Program;
(B)conduct an evaluation of the Program; and
(C)disseminate information described in this subsection to—
(i)eligible coalitions and other substance use and misuse organizations; and
(ii)the general public.
(4)Limitation on use of certain funds for evaluation of Program
Amounts for activities under paragraph (2)(B) may not be derived from amounts under section 1524(a) of this title except for amounts that are available under section 1524(b) of this title for administrative costs.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

Amendments

2019—Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(4)(A). See 2018 Amendment note below. 2018—Subsec. (b)(1)(A), (2)(C)(i). Pub. L. 115–271, § 8203(b)(4)(A), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), substituted “substance use and misuse” for “substance abuse”. 2001—Subsec. (b)(3). Pub. L. 107–82, § 1(e), added par. (3). Subsec. (b)(4). Pub. L. 107–82, § 1(f), added par. (4).

Statutory Notes and Related Subsidiaries

Effective Date

of 2019 AmendmentAmendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.

Reference

Citations & Metadata

Citation

21 U.S.C. § 1533

Title 21, Food and Drugs

Last Updated

Sep 22, 2026

Release point: 119-110